羚锐制药(600285) - 2022 Q3 - 季度财报

Financial Performance - The company's operating revenue for Q3 2022 was ¥774,345,720.40, representing an increase of 11.01% compared to the same period last year[7]. - The net profit attributable to shareholders for Q3 2022 was ¥134,827,539.03, reflecting a growth of 25.93% year-over-year[7]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥128,686,535.24, with a year-over-year increase of 24.00%[7]. - The basic earnings per share for Q3 2022 was ¥0.243, up by 28.57% compared to the same period last year[11]. - The diluted earnings per share for Q3 2022 was ¥0.236, an increase of 27.57% year-over-year[11]. - Total operating revenue for the first three quarters of 2022 reached ¥2,277,024,517.97, an increase of 10.9% compared to ¥2,053,040,234.42 in the same period of 2021[35]. - Net profit attributable to shareholders of the parent company for Q3 2022 was ¥405,415,302.27, up 23.7% from ¥327,555,622.87 in Q3 2021[38]. - The total comprehensive income for Q3 2022 was ¥395,758,779.73, an increase of 26.8% from ¥311,938,445.97 in Q3 2021[41]. Assets and Liabilities - The total assets at the end of Q3 2022 amounted to ¥4,101,139,526.85, which is an increase of 8.12% from the end of the previous year[11]. - The equity attributable to shareholders at the end of Q3 2022 was ¥2,445,759,727.64, reflecting a growth of 7.32% compared to the previous year[11]. - The company's total assets amounted to ¥4,101,139,526.85, compared to ¥3,793,087,404.03 in the previous year, reflecting a growth of 8.1%[35]. - The total current liabilities were CNY 1,578,034,170.94, compared to CNY 1,437,648,177.54 in the previous year, marking an increase of about 9.8%[32]. - The total liabilities amounted to CNY 1,647,707,560.48, compared to CNY 1,506,512,237.97 in the previous year, indicating a rise of about 9.3%[32]. Cash Flow - The net cash flow from operating activities for the year-to-date was ¥478,524,825.72, showing a decrease of 23.89%[11]. - The company reported a net cash inflow from operating activities of ¥2,417,437,578.46, slightly down from ¥2,433,894,109.37 in the same period of 2021[42]. - Operating cash inflow totaled $2,487,828,704.05, slightly down from $2,493,773,487.81 in the previous period[43]. - Operating cash outflow increased to $2,009,303,878.33 from $1,865,078,309.49, resulting in a net cash flow from operating activities of $478,524,825.72, down from $628,695,178.32[43]. - The net cash flow from investment activities was $166,220,807.69, a recovery from a negative $172,423,104.56 in the previous period[43]. - The net cash flow from financing activities was negative at -$324,915,930.88, compared to -$258,973,538.41 previously[46]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 37,112[19]. Research and Development - Research and development expenses for the first three quarters of 2022 were ¥68,187,400.25, an increase of 9.3% from ¥62,042,225.21 in the same period of 2021[35]. Other Financial Metrics - The company's cash and cash equivalents amounted to CNY 1,121,151,010.27, up from CNY 801,242,132.87 in the previous year, indicating a year-over-year increase of about 39.9%[26]. - Accounts receivable increased to CNY 266,795,621.48 from CNY 172,905,827.85, reflecting a growth of approximately 54.3%[26]. - The company's retained earnings reached CNY 1,341,996,603.11, an increase from CNY 1,218,777,634.44, representing a growth of approximately 10.1%[32]. - The company reported a significant increase in other receivables, which rose to CNY 40,108,444.73 from CNY 9,345,173.92, reflecting a growth of approximately 329.5%[26]. - Sales expenses for the first three quarters of 2022 were ¥1,091,706,144.65, an increase of 9.9% from ¥992,923,866.20 in the previous year[35]. Government Subsidies and Tax - The company received government subsidies amounting to ¥4,344,802.77 during the reporting period, totaling ¥32,676,609.86 for the year-to-date[12]. - The company received tax refunds amounting to $714,965.22 during the reporting period[43]. - Cash paid for various taxes rose to $316,727,958.78 from $282,751,594.30, indicating higher tax obligations[43]. Labor Costs - Cash paid to employees increased to $241,729,316.33 from $180,142,554.32, reflecting a rise in labor costs[43]. Product Development - The company has not disclosed any new product developments or market expansion strategies during the reporting period[24].